Rabeprazole and Naltrexone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Naltrexone (naltrexone). Common drug interactions include rheumatoid arthritis among females and electrolyte imbalance among males.

The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Naltrexone. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Naltrexone?

Naltrexone has active ingredients of naltrexone. eHealthMe is studying from 4,835 Naltrexone users. Check the latest studies of Naltrexone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

27 people who take Rabeprazole and Naltrexone together, and have interactions are studied.

Rabeprazole and Naltrexone drug interactions.

What are the common drug interactions of Rabeprazole and Naltrexone, by gender? *:

female:

  1. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  2. Abdominal pain
  3. Abdominal pain upper
  4. Balance disorder
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Body temperature fluctuation
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cestode infection (infection of the digestive tract by adult parasitic flatworms called cestodes or tapeworms)
  9. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  10. Constipation

male:

  1. Electrolyte imbalance
  2. Type 2 diabetes mellitus

What are the common drug interactions of Rabeprazole and Naltrexone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Agitation (state of anxiety or nervous excitement)
  2. Anxiety
  3. Confusional state
  4. Depression
  5. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  6. Dysphemia (stammering or stuttering)
  7. Hallucination (an experience involving the perception of something not present)
  8. Hostility
  9. Insomnia (sleeplessness)
  10. Irritability

40-49:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Balance disorder
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Body temperature fluctuation
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cestode infection (infection of the digestive tract by adult parasitic flatworms called cestodes or tapeworms)
  8. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  9. Constipation
  10. Decreased appetite

50-59:

  1. Cough
  2. Lower respiratory tract infection

60+:

  1. Electrolyte imbalance
  2. Type 2 diabetes mellitus

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 21 people, 77.78%
  2. Nasopharyngitis (inflammation of the nasopharynx): 17 people, 62.96%
  3. Nausea (feeling of having an urge to vomit): 16 people, 59.26%
  4. Headache (pain in head): 15 people, 55.56%
  5. Colitis (inflammation of colon): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and Naltrexone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rabeprazole and Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naltrexone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium and naltrexone (the active ingredients of Rabeprazole and Naltrexone, respectively), and Rabeprazole and Naltrexone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: